Clinical trial Recruiting at 1 site Observational Ages 2 to 7

Turkish version of ABILHAND-Kids Young CP: translation, adaptation, and reliability

Official title: Turkish Translation, Cross-Cultural Adaptation, Validity, and Reliability of the ABILHAND-Kids Young CP Scale

Run by Istanbul University - Cerrahpasa · NCT07894926 · Data updated 2026-11-12

A Turkish version of the ABILHAND-Kids Young CP questionnaire is being created and tested to see if it reliably measures manual ability in 2-to-7-year-olds with cerebral palsy, based on parent reports.

More Cerebral Palsy trials

Quick facts

Study typeObservational
Ages2 Years to 7 Years
SexAll
Enrollment100 (estimated)
SponsorIstanbul University - Cerrahpasa
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedOctober 30, 2026
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07894926 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2 to 7 with a confirmed diagnosis of cerebral palsy and whose caregiver can read Turkish and provide informed consent.

Probably not a fit

Children with conditions that independently affect manual ability beyond cerebral palsy or with recent upper limb surgery or significant cognitive/behavioral issues may not benefit from this tool.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational, cross-cultural study will translate the ABILHAND-Kids Young CP scale into Turkish and adapt it culturally for Turkish-speaking children with cerebral palsy. The process follows standard guidelines, including forward translation, synthesis, back-translation, expert review, and pilot testing. Construct validity and reliability will be examined using appropriate statistical methods to ensure the instrument is accurate and consistent for pediatric use in Turkey.

Why it matters

Potential benefit: If successful, clinicians in Turkey will have a validated, culturally appropriate tool to assess how well children with cerebral palsy use their hands in daily activities.

How similar studies have gone: Cross-cultural adaptations of the ABILHAND family have shown good validity and reliability in other languages, supporting methodological feasibility for Turkish translation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 2 to 7 years
* Confirmed diagnosis of Cerebral Palsy by a specialist physician
* Parent or primary caregiver having Turkish reading and comprehension ability
* Written informed consent provided by the parent or legal guardian

Exclusion Criteria:

* Presence of additional neurological or orthopedic conditions independently affecting manual ability other than cerebral palsy
* History of upper limb surgical intervention in the last 6 months
* Severe cognitive or behavioral problems that prevent the administration of the scale
* Incomplete or improperly filled questionnaire forms

Where it's running

  • Istanbul University-Cerrahpasa, Faculty of Health Sciences
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Sezen Karabörklü Argut, Study Principal Investigator — Istanbul University-Cerrahpasa, Faculty of Health Sciences
  • Study coordinator: Ayşe Gül Türkmenoğlu, BSc, PT
  • Email: aysegulturkmenoglu@ogr.iuc.edu.tr
  • Phone: +90 537 555 69 11

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.